Search

everythinglearnresearchcommunity

for

Search:↓

Silencing SFRP1 alone promotes hair growth, but adding DKK1 does not help.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Excess androgens may cause PCOS, not just be a symptom.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

A new gene variant causes glucocorticoid resistance in a mother and son.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Meloside A may help protect hair cells from damage linked to hair loss.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Early onset hair loss linked to genetics and androgen levels.

Androgens can both increase body hair and cause scalp hair loss.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.